Moe SM - Search Results

1

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.

Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM. Block GA, et al. Among authors: moe sm. JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468. JAMA. 2017. PMID: 28097356 Free article. Clinical Trial.

2

Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.

Ouseph R, Leiser JD, Moe SM. Ouseph R, et al. Among authors: moe sm. J Am Soc Nephrol. 1996 Mar;7(3):497-505. doi: 10.1681/ASN.V73497. J Am Soc Nephrol. 1996. PMID: 8704117 Clinical Trial.

3

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.

Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ. Lindberg JS, et al. Among authors: moe sm. Kidney Int. 2003 Jan;63(1):248-54. doi: 10.1046/j.1523-1755.2003.00720.x. Kidney Int. 2003. PMID: 12472790 Free article. Clinical Trial.

4

Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.

Moe SM, Drüeke TB. Moe SM, et al. Am J Nephrol. 2003 Nov-Dec;23(6):369-79. doi: 10.1159/000073945. Epub 2003 Oct 9. Am J Nephrol. 2003. PMID: 14551461 Free article. Review.

5

Disturbances of bone and mineral metabolism in chronic kidney disease: an international initiative to improve diagnosis and treatment.

Drüeke TB, Moe SM. Drüeke TB, et al. Among authors: moe sm. Nephrol Dial Transplant. 2004 Mar;19(3):534-6. doi: 10.1093/ndt/gfh034. Nephrol Dial Transplant. 2004. PMID: 14767004 Review. No abstract available.

6

A bridge to improving healthcare outcomes and quality of life.

Moe SM, Drüeke TB. Moe SM, et al. Am J Kidney Dis. 2004 Mar;43(3):552-7. doi: 10.1053/j.ajkd.2003.12.002. Am J Kidney Dis. 2004. PMID: 14981614 No abstract available.

7

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG. Block GA, et al. Among authors: moe sm. N Engl J Med. 2004 Apr 8;350(15):1516-25. doi: 10.1056/NEJMoa031633. N Engl J Med. 2004. PMID: 15071126 Free article. Clinical Trial.

8

Calcification or classification?

Chertow GM, Moe SM. Chertow GM, et al. Among authors: moe sm. J Am Soc Nephrol. 2005 Feb;16(2):293-5. doi: 10.1681/ASN.2004121115. Epub 2005 Jan 12. J Am Soc Nephrol. 2005. PMID: 15647332 No abstract available.

9

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drüeke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ. Moe SM, et al. Kidney Int. 2005 Feb;67(2):760-71. doi: 10.1111/j.1523-1755.2005.67139.x. Kidney Int. 2005. PMID: 15673327 Free article. Clinical Trial.

10

Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).

Moe SM, Reslerova M, Ketteler M, O'neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX. Moe SM, et al. Kidney Int. 2005 Jun;67(6):2295-304. doi: 10.1111/j.1523-1755.2005.00333.x. Kidney Int. 2005. PMID: 15882271 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page